<VariationArchive RecordType="classified" VariationID="14368" VariationName="NM_000302.4(PLOD1):c.1651-2del" VariationType="Deletion" Accession="VCV000014368" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-08-06" DateCreated="2017-12-26" MostRecentSubmission="2017-12-26">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="29407" VariationID="14368">
      <GeneList>
        <Gene Symbol="PLOD1" FullName="procollagen-lysine,2-oxoglutarate 5-dioxygenase 1" GeneID="5351" HGNC_ID="HGNC:9081" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1p36.22</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="11934717" stop="11975537" display_start="11934717" display_stop="11975537" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="11994723" stop="12035598" display_start="11994723" display_stop="12035598" Strand="+" />
          </Location>
          <OMIM>153454</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000302.4(PLOD1):c.1651-2del</Name>
      <CanonicalSPDI>NC_000001.11:11966984:A:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1p36.22</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="11966985" stop="11966985" display_start="11966985" display_stop="11966985" variantLength="1" positionVCF="11966984" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="12027042" stop="12027042" display_start="12027042" display_stop="12027042" variantLength="1" positionVCF="12027041" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.12027042del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.12027042del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.11966985del" Assembly="GRCh38">
            <Expression>NC_000001.11:g.11966985del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008159.1" sequenceAccession="NG_008159" sequenceVersion="1" change="g.37297del">
            <Expression>NG_008159.1:g.37297del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_089381.1" sequenceAccession="NG_089381" sequenceVersion="1" change="g.669del">
            <Expression>NG_089381.1:g.669del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_089382.1" sequenceAccession="NG_089382" sequenceVersion="1" change="g.168del">
            <Expression>NG_089382.1:g.168del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001316320.2" sequenceAccession="NM_001316320" sequenceVersion="2" change="c.1792-2del">
            <Expression>NM_001316320.2:c.1792-2del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000302.4" sequenceAccession="NM_000302" sequenceVersion="4" change="c.1651-2del" MANESelect="true">
            <Expression>NM_000302.4:c.1651-2del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA281013" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="153454.0005" DB="OMIM" />
        <XRef Type="rs" ID="797044447" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff reviewed the sequence information reported in PubMed 9450904 Fig. 3 to determine the location of this allele on the current reference sequence.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000302.4(PLOD1):c.1651-2del AND Ehlers-Danlos syndrome, kyphoscoliotic type 1" Accession="RCV000015444" Version="28">
        <ClassifiedConditionList TraitSetID="3964">
          <ClassifiedCondition DB="MedGen" ID="C0268342">Ehlers-Danlos syndrome, kyphoscoliotic type 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1998-01-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="1998-01-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2017-12-26" MostRecentSubmission="2017-12-26">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">9450904</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3964" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1586" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Nevo syndrome</ElementValue>
                <XRef ID="Nevo+syndrome/5215" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Ehlers-Danlos syndrome, kyphoscoliotic type 1</ElementValue>
                <XRef ID="MONDO:0016002" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EHLERS-DANLOS SYNDROME, OCULAR-SCOLIOTIC TYPE</ElementValue>
                <XRef Type="MIM" ID="225400" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EHLERS-DANLOS SYNDROME, TYPE VIA</ElementValue>
                <XRef Type="MIM" ID="225400" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ehlers-Danlos syndrome, hydroxylysine-deficient</ElementValue>
                <XRef ID="25606004" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">EDS6A</ElementValue>
                <XRef Type="MIM" ID="225400" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">EDSKSCL1</ElementValue>
                <XRef Type="MIM" ID="225400" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">EDS6</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000522328" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000529376" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000525812" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500398" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000561718" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000509007" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000510821" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000514633" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000515704" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">PLOD1-related kyphoscoliotic Ehlers-Danlos syndrome (kEDS) is an autosomal recessive generalized connective tissue disorder characterized by hypotonia, early-onset kyphoscoliosis, and generalized joint hypermobility in association with skin fragility and ocular abnormality. Intelligence is normal. Life span may be normal, but affected individuals are at risk for rupture of medium-sized arteries. Adults with severe kyphoscoliosis are at risk for complications from restrictive lung disease, recurrent pneumonia, and cardiac failure.</Attribute>
                <XRef ID="NBK1462" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Ehlers-Danlos Syndrome, Kyphoscoliotic Form</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301635</ID>
                <ID Source="BookShelf">NBK1462</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2010">
                <ID Source="pmc">2987428</ID>
              </Citation>
              <XRef ID="1900" DB="Orphanet" />
              <XRef ID="C0268342" DB="MedGen" />
              <XRef ID="MONDO:0016002" DB="MONDO" />
              <XRef Type="MIM" ID="225400" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="35709" SubmissionDate="2017-12-21" DateLastUpdated="2017-12-26" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="153454.0005_EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 1" title="PLOD1, IVS15, 1-BP DEL, A, -2_EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 1" />
        <ClinVarAccession Accession="SCV000035709" DateUpdated="2017-12-26" DateCreated="2013-04-04" Type="SCV" Version="4" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1998-01-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a patient with kyphoscoliotic Ehlers-Danlos syndrome (EDSKSCL1; 225400) with markedly reduced lysyl hydroxylase activity, Pousi et al. (1998) found compound heterozygosity for a deletion mutation and a splicing defect in the PLOD gene. Northern analysis of RNA isolated from skin fibroblasts of the patient demonstrated truncated lysyl hydroxylase mRNA. PCR and sequence analysis confirmed the truncation and indicated that the cells contained 2 types of shortened mRNAs, 1 lacking sequence corresponding to exon 16 and the other lacking sequence corresponding to exon 17. Analysis of genomic DNA showed deletion of the penultimate adenosine from the 3-prime end of intron 15 of 1 allele. This defect appeared to be responsible for skipping of exon 16 sequences from the transcript. The other allele, inherited from the mother, contained an Alu-Alu recombination with deletion of about 3,000 bp, including exon 17 (153454.0006). The identified mutations in exon 16 and exon 17 did not alter the reading frame of the transcripts.</Attribute>
              <Citation>
                <ID Source="PubMed">9450904</ID>
              </Citation>
              <XRef DB="OMIM" ID="225400" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PLOD1" />
          </GeneList>
          <Name>PLOD1, IVS15, 1-BP DEL, A, -2</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">IVS15, 1-BP DEL, A, -2</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="153454.0005" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 1</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="35709" TraitType="Disease" MappingType="Name" MappingValue="EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 1" MappingRef="Preferred">
        <MedGen CUI="C0268342" Name="Ehlers-Danlos syndrome, kyphoscoliotic type 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

